# Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

> **NCT02118792** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 764 (actual)

## Conditions studied

- Dermatitis, Atopic

## Interventions

- **DRUG:** AN2728 Topical Ointment, 2%
- **DRUG:** Matching vehicle control

## Key facts

- **NCT ID:** NCT02118792
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 764 (ACTUAL)
- **Last updated:** 2017-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02118792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02118792, "Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02118792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*